IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $383,351 | -7.5% | 39,808 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $414,641 | -1.5% | 38,970 | -2.6% | 0.00% | -25.0% |
| Q1 2023 | $420,821 | -12.7% | 40,002 | +2.8% | 0.00% | -20.0% |
| Q4 2022 | $482,144 | +23.6% | 38,914 | +3.4% | 0.01% | +25.0% |
| Q3 2022 | $390,000 | -12.9% | 37,625 | -3.1% | 0.00% | 0.0% |
| Q2 2022 | $448,000 | -15.3% | 38,834 | -7.6% | 0.00% | 0.0% |
| Q1 2022 | $529,000 | +8.8% | 42,025 | +0.9% | 0.00% | 0.0% |
| Q4 2021 | $486,000 | -11.2% | 41,651 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $547,000 | +2.2% | 41,913 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $535,000 | +8.1% | 41,566 | -6.1% | 0.00% | 0.0% |
| Q1 2021 | $495,000 | -1.4% | 44,274 | +0.5% | 0.00% | -20.0% |
| Q4 2020 | $502,000 | +22.1% | 44,074 | -3.5% | 0.01% | +25.0% |
| Q3 2020 | $411,000 | +17.4% | 45,685 | +34.7% | 0.00% | -20.0% |
| Q2 2020 | $350,000 | -5.7% | 33,923 | -7.9% | 0.01% | -16.7% |
| Q1 2020 | $371,000 | – | 36,815 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |